About this document
Axadia-Afnet 8 by Karatpetch Tongkate is a document available to read on EtoBox.
The AXADIA-AFNET 8 study compared the safety and efficacy of apixaban and the vitamin K antagonist phenprocoumon in patients with atrial fibrillation on chronic hemodialysis. Results showed no significant differences in safety or efficacy outcomes between the two treatments, with high event rates for cardiovascular complications remaining in both groups. The study highlights the need for larger trials to optimize anticoagulation strategies for this high-risk population.
- Author
- Karatpetch Tongkate
- Language
- EN